DR. JIN HYUNG YOO, M.D.
Osteopathic Medicine at Maryland Ave, Chicago, IL
License number
Illinois 125-061005
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
5841 S Maryland Ave, Chicago, IL 60637
Phone
(773) 702-1000
Personal information
See more information about JIN HYUNG YOO at radaris.comName
Address
Phone
3231 Greenleaf Ave, Wilmette, IL 60091
683 N Western Ln, Addison, IL 60101
1282 Pine Valley Dr APT 203, Schaumburg, IL 60173
2315 Mast Ct, Flossmoor, IL 60422
2315 Mast Ct, Flossmoor, IL 60422
Professional information
Dr. Jin H Yoo, Chicago IL - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
5841 S Maryland Ave, Chicago 60637
(773) 702-1000 (Phone), (773) 702-2230 (Fax)
UNIVERSITY OF CHICAGO MEDICAL CENTER
5841 S Maryland Ave, Chicago 60637
(773) 702-9200 (Phone), (773) 702-3538 (Fax)
(773) 702-1000 (Phone), (773) 702-2230 (Fax)
UNIVERSITY OF CHICAGO MEDICAL CENTER
5841 S Maryland Ave, Chicago 60637
(773) 702-9200 (Phone), (773) 702-3538 (Fax)
Languages:
English
Dr. Jin Hyung Yoo, Chicago IL - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
5841 S Maryland Ave, Chicago 60637
(773) 702-1000 (Phone)
(773) 702-1000 (Phone)
Languages:
English
Education:
Medical School
University of Toledo
Graduated: 2012
University of Toledo
Graduated: 2012
Jin Yoo
Location:
Greater Chicago Area
Industry:
Human Resources
Composition And Process
US Patent:
3949013, Apr 6, 1976
Filed:
Apr 15, 1974
Appl. No.:
5/460862
Inventors:
Jin Sun Yoo - Riverdale IL
Robert Koncos - Park Forest IL
Robert Koncos - Park Forest IL
Assignee:
Atlantic Richfield Company - Philadelphia PA
International Classification:
C07C 321
US Classification:
26068315D
Abstract:
A solid phase catalyst for the polymerization, including oligomerization and codimerization, of olefins is provided by combining (A) a nickel source, (B) an electron donor ligand, and (C) a Lewis acid-reducing agent, in molar ratios of (B) to (A) of about 3 to 10:1 and (C) to (A) of about 2 or 3 to 40:1. Preferred catalyst components are nickel acetylacetonate, tri-n-butylphosphine, and ethylaluminum sesquichloride. Butenes and propylene are codimerized to provide yields of up to about 60% heptenes.
University Relations At Zebra Technologies
Position:
University Relations at Zebra Technologies
Location:
Greater Chicago Area
Industry:
Printing
Work:
Zebra Technologies
-
University Relations
Zirconium Phosphine Complex Catalyst
US Patent:
4026822, May 31, 1977
Filed:
Jul 12, 1974
Appl. No.:
5/488134
Inventors:
John F. Motier - Dolton IL
Jin Sun Yoo - Riverdale IL
Jin Sun Yoo - Riverdale IL
Assignee:
Atlantic Richfield Company - Philadelphia PA
International Classification:
B01J 3102
US Classification:
252429B
Abstract:
A catalyst composition for the polymerization, including oligomerization and codimerization, of olefins is provided by combining (A) zirconium, (B) a monophosphine electron donor ligand, and (C) a Lewis acid-reducing agent, in molar ratios of (B) to (A) of about 1 to 10:1 and (C) to (A) of about 1 to 40:1. Preferred catalyst components are zirconium acetylacetonate, triphenylphosphine or tri-n-butylphosphine and ethylaluminum sesquichloride. The catalyst composition of this invention may be employed in the dimerization of olefins such as propylene as well as in codimerization reactions, such as the preparation of heptenes from propylene and butenes.
Jin Yoo
Location:
Greater Chicago Area
Industry:
Management Consulting